Has Andrew Greenberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $85,898 in general payments to Andrew Greenberg, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Greenberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Greenberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Greenberg, MD

Hand Surgery · Great Neck, NYNPI 1811211980

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $56,006 of the $85,898 with a category attached, or 65.2%. 24 manufacturers reported payments, led by Medartis Inc. at 53.0% of the total. Reporting peaked in 2019 at $51,965 and has fallen 60.0% since, to $20,787 in 2025. Among hand surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$85,898in general payments, 2019–2025

Across 143 payments — averaging $600.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medartis Inc.$46K
Arthrex$37K
Bioventus LLC$448
Acumed LLC$339
Zimmer Biomet$332
Stryker$304
plus $1K from 18 others

What the payments were for

Consulting fees$20,67524%
Speaking & faculty fees$56,00665%
Travel & lodging$3,9525%
Food & beverage$5,0896%
Entertainment$1760%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medartis Inc.	27	$45,558
Arthrex	54	$37,426
Bioventus LLC	11	$448
Acumed LLC	3	$339
Zimmer Biomet	3	$332
Stryker	4	$304
Endo Pharmaceuticals Inc.	12	$246
Johnson & Johnson(2 entities)	3	$185
Hitachi Healthcare Americas Corp.	1	$176
DJO, LLC	2	$161
Linvatec Corporation	3	$161
Ferring Pharmaceuticals Inc.	7	$137
AbbVie	1	$95
Arcuro Medical Inc	1	$75
Medtronic	1	$58
Orthofix Medical, Inc.	1	$49
Endo USA, Inc.	2	$47
Si-bone, Inc.	1	$21
Biomarin Pharmaceutical Inc.	1	$17
Kowa Pharmaceuticals America, Inc.	1	$16
KCI USA, Inc.	1	$12
Sanofi-aventis U.S. LLC	1	$12
Nevro Corp.	1	$12
Convatec Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

APTUS$45,310
Anatomic Radial Head System$291
REUNION$275
CMF$230
CAPITAL CONSUMABLES CONSUMABLES RF BRF$175
Polarus 3 Solution$148
Clavicle Plating System$143
Acu-Loc Wrist Plating System$143
Comprehensive Shoulder System$141
Durolane$140
Exogen$137
COMPREHENSIVE$135
IM NAILS$118

How this compares

$85,898 in reported general payments places this provider in the 90th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York →

Medicare billing

Part B allowed, 2024

$458,618

Medicare patients

807

Services billed

4,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	122	$1,686
Meloxicam	85	$320
Methylprednisolone	25	$200

Paid to pharmacies, not to this prescriber.

Other hand surgery in Great Neck

Peter SteinGreat Neck$131K
David TuckmanGreat Neck$96K
Scott WolfeNy$251K
Nader PaksimaNew York$171K
Michael HausmanNew York$128K
Otis BarronNew York$122K
Kevin SetterEast Syracuse$118K
Nathan EverdingSyracuse$98K
Dan ZlotolowNew York$91K
Steven KoehlerBronx$64K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →